Recombinant Human Insulin-like Growth Factor-Binding Protein 5 (Human IGF-BP5) _ 92204ESIGF BPs control the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently, there are seven named IGF BPs that form high affinity complexes with both IGF I and IGF II. IGF BP5 is a 28. 6 kDa, cysteine rich, secreted protein produced by vascular smooth muscle cells. It is the major IGF binding protein present in bone tissue and helps potentiate the action of IGF I on smooth muscle cells, fibroblasts, and

10181: Add dissociation component A and termination dissociation component B together

is expressed in human but not mouse

The biological activity determined by a chemotaxis bioassay using human monocytes is in a concentration of 10-100 ng/ml

fully glycosylated form has an apparent molecular weight of about 25

rare disruptions of the R-Spondin 1 gene are associated with tendencies for XX sex reversal (phenotypic male) or hermaphroditism

Cited from " NNMT enriches for AQP5+ cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma

secreted protein produced by vascular smooth muscle cells

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma

sourced from German MB

The biological activity determined by a chemotaxis bioassay using human peripheral blood eosinophils is in a concentration range of 0

Ala21-Thr154